Comparing blood markers in coronary artery disease
Part of Heart & circulation clinical trials.
This study looks at blood proteins and other molecules in people with different types of coronary artery disease. The goal is to see how these markers differ between those with blocked arteries, those with narrowed arteries, and those with no artery disease. This may help doctors better understand the disease and improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and a patient at the University of Sao Paulo General Hospital.
- You need a recent imaging test (CCTA or ICA) showing either no plaque, non-obstructive plaque (less than 50% blockage), or obstructive plaque (50% or more blockage).
- You cannot have any heart disease not caused by plaque, like valve problems or heart muscle disease.
- Your kidney function must be adequate (creatinine clearance over 30).
- You cannot have had a heart attack or unstable angina in the last 90 days.
- You cannot be a current smoker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares people with very severe coronary artery disease to those without significant disease, using heart imaging data. It aims to understand what differs between extreme cases and how that information could guide future care.
This study collects blood samples and images from patients with heart muscle damage or those undergoing coronary angiography. The goal is to find new biomarkers that could improve diagnosis and treatment of coronary artery disease.
This study looks at people with coronary artery disease (narrowed or blocked heart arteries) to see how different imaging and function tests can help predict outcomes. If you've had a heart procedure or test showing blockages, you might be eligible.
This study looks at real-world outcomes for people with narrowed heart arteries (coronary artery disease). It may include those treated with stents (PCI) or medicines. Doctors will use a special computer tool to measure the severity of blockages and track health over time.
This trial uses special imaging to look at how blood flows through the heart's arteries. It aims to see if certain blood flow patterns can predict where harmful plaque (fatty buildups) may grow, which could help prevent future heart problems.
This study looks at why some people have chest pain or other heart symptoms even when their main heart arteries are not blocked. It tests whether inflammation in the small blood vessels of the heart might cause these symptoms, and aims to understand how to better diagnose and treat this condition.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.